Novelix Pharmaceuticals Ltd — Others, 26-08-2025: AGM/EGM

Novelix Pharmaceuticals has announced its 31st Annual General Meeting via video conference. Key agenda items include adopting the audited annual financial statements for FY 2024-25 and re-appointing a Non-Executive Director. Shareholders will also consider approving an increase in the company's borrowing limit to Rs 500 Cr, along with the ability to create charges on company assets to secure these funds. Further approvals involve making investments, giving loans, or providing guarantees up to Rs 500 Cr, including to related parties. Additionally, new Independent and Non-Executive Non-Independent Directors will be appointed.